Goldman Sachs Group Inc Ibere Pharmaceuticals Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 May 14, 2024	SELL	$0.11 - $9.94 $550 - $49,700	-5,000 Reduced 8.93%	50,995 $505,000
Q3 2022 Nov 10, 2022	SELL	$0.11 - $9.94 $550 - $49,700	-5,000 Reduced 8.93%	50,995 $0
Q2 2022 May 14, 2024	BUY	$9.77 - $9.84 $547,071 - $550,990	55,995 New	55,995 $549,000
Q3 2021 Nov 10, 2021	BUY	$9.61 - $9.78 $538,111 - $547,631	55,995 New	55,995 $543,000

Others Institutions Holding IBER

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About IBERE PHARMACEUTICALS

Ticker IBER
Exchange NYSE
Sector Financial Services
Industry Shell Companies
Shares Outstandng 13,800,000
Description
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

More about IBER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.